Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;31(40):6656-6671.
doi: 10.2174/0109298673255656231003111621.

Research Progress of Pyroptosis in Renal Diseases

Boyan Hu  1   2   3 , Kuai Ma  4 , Wei Wang  2   3 , Zhongyu Han  5 , Mingxuan Chi  2   3 , Moussa Ide Nasser  6 , Chi Liu  2   3
Affiliations
Review

Research Progress of Pyroptosis in Renal Diseases

Boyan Hu et al. Curr Med Chem. 2024.

Abstract

Kidney diseases, particularly Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD), are identified as global public health issues affecting millions of individuals. In addition, the frequency of renal diseases in the population has increased dramatically and rapidly in recent years. Renal disorders have become a significant public health burden. The pathophysiology of renal diseases is significantly connected with renal cell death, including apoptosis, necrosis, necroptosis, ferroptosis, pyroptosis, and autophagy, as is now recognized. Unlike other forms of cell death, pyroptosis is a unique planned cell death (PCD). Scientists have proven that pyroptosis is crucial in developing various disorders, and this phenomenon is gaining increasing attention. It is considered a novel method of inflammatory cell death. Intriguingly, inflammation is among the most significant pathological characteristics of renal disease. This study investigates the effects of pyroptosis on Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD), Diabetic Nephropathy (DN), Immunoglobulin A (IgA) Nephropathy, and Lupus Nephritis (LN) to identify novel therapeutic targets for kidney diseases.

Keywords: Pyroptosis; acute kidney injury; chronic kidney disease; diabetic nephropathy; kidney disease; lupus nephritis..

PubMed Disclaimer

References

    1. de Vasconcelos N.M.; Lamkanfi M.; Recent insights on inflammasomes, gasdermin pores, and pyroptosis. Cold Spring Harb Perspect Biol 2020,12(5),a036392 - DOI - PubMed
    1. Xia S.; Hollingsworth L.R.; Wu H.; Mechanism and regulation of gasdermin-mediated cell death. Cold Spring Harb Perspect Biol 2020,12(3),a036400 - DOI - PubMed
    1. Galluzzi L.; Vitale I.; Aaronson S.A.; Abrams J.M.; Adam D.; Agostinis P.; Alnemri E.S.; Altucci L.; Amelio I.; Andrews D.W.; Annicchiarico-Petruzzelli M.; Antonov A.V.; Arama E.; Baehrecke E.H.; Barlev N.A.; Bazan N.G.; Bernassola F.; Bertrand M.J.M.; Bianchi K.; Blagosklonny M.V.; Blomgren K.; Borner C.; Boya P.; Brenner C.; Campanella M.; Candi E.; Carmona-Gutierrez D.; Cecconi F.; Chan F.K.M.; Chandel N.S.; Cheng E.H.; Chipuk J.E.; Cidlowski J.A.; Ciechanover A.; Cohen G.M.; Conrad M.; Cubillos-Ruiz J.R.; Czabotar P.E.; D’Angiolella V.; Dawson T.M.; Dawson V.L.; De Laurenzi V.; De Maria R.; Debatin K.M.; DeBerardinis R.J.; Deshmukh M.; Di Daniele N.; Di Virgilio F.; Dixit V.M.; Dixon S.J.; Duckett C.S.; Dynlacht B.D.; El-Deiry W.S.; Elrod J.W.; Fimia G.M.; Fulda S.; García-Sáez A.J.; Garg A.D.; Garrido C.; Gavathiotis E.; Golstein P.; Gottlieb E.; Green D.R.; Greene L.A.; Gronemeyer H.; Gross A.; Hajnoczky G.; Hardwick J.M.; Harris I.S.; Hengartner M.O.; Hetz C.; Ichijo H.; Jäättelä M.; Joseph B.; Jost P.J.; Juin P.P.; Kaiser W.J.; Karin M.; Kaufmann T.; Kepp O.; Kimchi A.; Kitsis R.N.; Klionsky D.J.; Knight R.A.; Kumar S.; Lee S.W.; Lemasters J.J.; Levine B.; Linkermann A.; Lipton S.A.; Lockshin R.A.; López-Otín C.; Lowe S.W.; Luedde T.; Lugli E.; MacFarlane M.; Madeo F.; Malewicz M.; Malorni W.; Manic G.; Marine J.C.; Martin S.J.; Martinou J.C.; Medema J.P.; Mehlen P.; Meier P.; Melino S.; Miao E.A.; Molkentin J.D.; Moll U.M.; Muñoz-Pinedo C.; Nagata S.; Nuñez G.; Oberst A.; Oren M.; Overholtzer M.; Pagano M.; Panaretakis T.; Pasparakis M.; Penninger J.M.; Pereira D.M.; Pervaiz S.; Peter M.E.; Piacentini M.; Pinton P.; Prehn J.H.M.; Puthalakath H.; Rabinovich G.A.; Rehm M.; Rizzuto R.; Rodrigues C.M.P.; Rubinsztein D.C.; Rudel T.; Ryan K.M.; Sayan E.; Scorrano L.; Shao F.; Shi Y.; Silke J.; Simon H.U.; Sistigu A.; Stockwell B.R.; Strasser A.; Szabadkai G.; Tait S.W.G.; Tang D.; Tavernarakis N.; Thorburn A.; Tsujimoto Y.; Turk B.; Vanden Berghe T.; Vandenabeele P.; Vander Heiden M.G.; Villunger A.; Virgin H.W.; Vousden K.H.; Vucic D.; Wagner E.F.; Walczak H.; Wallach D.; Wang Y.; Wells J.A.; Wood W.; Yuan J.; Zakeri Z.; Zhivotovsky B.; Zitvogel L.; Melino G.; Kroemer G.; Molecular mechanisms of cell death: Recommendations of the nomenclature committee on cell death 2018. Cell Death Differ 2018,25(3),486-541 - DOI - PubMed
    1. Kayagaki N.; Stowe I.B.; Lee B.L.; O’Rourke K.; Anderson K.; Warming S.; Cuellar T.; Haley B.; Roose-Girma M.; Phung Q.T.; Liu P.S.; Lill J.R.; Li H.; Wu J.; Kummerfeld S.; Zhang J.; Lee W.P.; Snipas S.J.; Salvesen G.S.; Morris L.X.; Fitzgerald L.; Zhang Y.; Bertram E.M.; Goodnow C.C.; Dixit V.M.; Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 2015,526(7575),666-671 - DOI - PubMed
    1. Lin J.; Cheng A.; Cheng K.; Deng Q.; Zhang S.; Lan Z.; Wang W.; Chen J.; New insights into the mechanisms of pyroptosis and implications for diabetic kidney disease. Int J Mol Sci 2020,21(19),7057 - DOI - PubMed

MeSH terms

LinkOut - more resources